6ZA8
Crystal structure of the neurotensin receptor 1 in complex with the small-molecule partial agonist RTI-3a
This is a non-PDB format compatible entry.
Entity
Entity ID | Chain ID | Description | Type | Chain length | Formula weight | Number of molecules | DB Name (Accession) | Biological source | Descriptive keywords |
1 | AAA | Neurotensin receptor type 1,Neurotensin receptor type 1,Neurotensin receptor 1 (NTSR1),Neurotensin receptor 1 (NTSR1),Neurotensin receptor type 1,Neurotensin receptor 1 (NTSR1),Neurotensin receptor 1 (NTSR1) | polymer | 482 | 53089.2 | 1 | UniProt (P20789) Pfam (PF00001) In PDB | Rattus norvegicus (Rat) | NTR1,High-affinity levocabastine-insensitive neurotensin receptor,NTRH |
2 | AAA | (2~{S})-2-[[1-(7-chloranylquinolin-4-yl)-5-(2,6-dimethoxyphenyl)pyrazol-3-yl]carbonylamino]-4-methyl-pentanoic acid | non-polymer | 523.0 | 1 | Chemie (SR5) |
Sequence modifications
AAA: 50 - 371 (UniProt: P20789)
AAA: 372 - 380 (PDB: 6ZA8)
AAA: 381 - 545 (PDB: 6ZA8)
PDB | External Database | Details |
---|---|---|
Gly 46 | - | expression tag |
Pro 47 | - | expression tag |
Gly 48 | - | expression tag |
Ser 49 | - | expression tag |
Gly 83 | Ser 83 | engineered mutation |
Leu 86 | Ala 86 | engineered mutation |
Arg 101 | Thr 101 | engineered mutation |
Asp 103 | His 103 | engineered mutation |
Tyr 105 | His 105 | engineered mutation |
Phe 119 | Leu 119 | engineered mutation |
Leu 121 | Met 121 | engineered mutation |
Asp 124 | Glu 124 | engineered mutation |
Lys 143 | Arg 143 | engineered mutation |
Glu 150 | Asp 150 | engineered mutation |
Val 161 | Ala 161 | engineered mutation |
Leu 167 | Arg 167 | engineered mutation |
Leu 213 | Arg 213 | engineered mutation |
Leu 234 | Val 234 | engineered mutation |
Arg 235 | Lys 235 | engineered mutation |
Leu 240 | Val 240 | engineered mutation |
Ala 253 | Ile 253 | engineered mutation |
Ala 260 | Ile 260 | engineered mutation |
Arg 262 | Asn 262 | engineered mutation |
Arg 263 | Lys 263 | engineered mutation |
- | Glu 273 | deletion |
- | Gln 274 | deletion |
- | Gly 275 | deletion |
- | Arg 276 | deletion |
- | Val 277 | deletion |
- | Cys 278 | deletion |
- | Thr 279 | deletion |
- | Val 280 | deletion |
- | Gly 281 | deletion |
- | Thr 282 | deletion |
- | His 283 | deletion |
- | Asn 284 | deletion |
- | Gly 285 | deletion |
- | Leu 286 | deletion |
- | Glu 287 | deletion |
- | His 288 | deletion |
- | Ser 289 | deletion |
- | Thr 290 | deletion |
Arg 305 | His 305 | engineered mutation |
Val 332 | Cys 332 | engineered mutation |
Ala 342 | Phe 342 | engineered mutation |
Ser 354 | Thr 354 | engineered mutation |
Val 358 | Phe 358 | engineered mutation |
Ala 362 | Ser 362 | engineered mutation |
AAA: 381 - 545 (PDB: 6ZA8)
Sequence viewer
Contents of the asymmetric unit
Polymers | Number of chains | 1 |
Total formula weight | 53089.2 | |
Non-Polymers* | Number of molecules | 1 |
Total formula weight | 523.0 | |
All* | Total formula weight | 53612.2 |